Funding Affordable Healthcare in India

If you run a healthcare business in India and you've never had a conversation with a foundation or a development institution, you're in a large group. It's an odd one to be in, because health access attracts more patient capital in this country than almost any other theme.

Dedicated blended finance facilities have been built around Indian healthcare. Global health foundations have been active here for decades. Development institutions fund hospitals, diagnostics and health financing. Outcome-based structures have been piloted in maternal and newborn health. The money is not theoretical and it is not small.

And yet the sector is also where I see the qualification test bite hardest. The reason is worth understanding before you spend a quarter on it. A great deal of Indian healthcare is already commercially fundable, and patient capital has no business going there.

01The line that actually matters

Private equity and venture capital have been enthusiastic about Indian healthcare for years. Urban multi-specialty hospitals. Single-specialty chains in metros. Premium diagnostics. Health insurance. Digital health platforms serving people with smartphones and disposable income.

None of that needs concessional capital, and a foundation asked to subsidise it would decline on principle rather than on merit.

The gap sits somewhere else. Secondary care in towns where the nearest decent hospital is three hours away. Diagnostics in districts a national chain has decided aren't worth the capex. Primary care for households paying out of pocket, where the alternative is going without care. Devices designed down to a price point rather than up to a specification. Supply chains reaching pharmacies that no distributor services properly.

What these businesses share is an obvious need and economics too weak to have drawn commercial capital. That is the gap patient money exists to close.

Which means the first question for any healthcare founder considering this lane isn't "are we impact." It's "would a PE fund have written this cheque anyway?" If the honest answer is yes, the commercial lane is faster and you should take it.

03Where each sub-segment tends to land

A rough map, as honest as I can make it.

• Diagnostics in tier-2 and beyond. This is often the cleanest case in the sector. First-time access is easy to evidence, geography is in the data, and the capex-heavy model genuinely struggles to attract commercial funding outside metros.
• Secondary care hospitals in smaller towns. These are strong on need, and the additionality argument is usually straightforward. The complication is that these are capital-intensive and the instrument question matters more than the impact question.
• Primary care and clinic chains. It depends entirely on who walks in. Serving households paying out of pocket for care they'd otherwise skip is a real case. Serving salaried urban customers is a commercial business with good margins.
• Affordable medical devices. These are frequently compelling, particularly where the product is designed to a price point that opens access. Often a technical-assistance and grant conversation at the early stage rather than an equity one.
• Digital health. This is the hardest to qualify, and founders are often surprised by that. Much of it serves people who already had access and are now getting it more conveniently, which is a genuine product improvement and not an access story. It qualifies when it reaches people who were outside the system.
• Health financing and insurance for low-income households. This sits across health and financial inclusion, and often has the widest funder shelf of anything on this list.

05Where to start on funding affordable healthcare

If you're running a healthcare business that serves people the system generally skips, three things are worth doing before you approach anyone.

• Work out honestly whether commercial capital would fund this. If it would, stop here and go there.
• Go into your own records and assemble what you already hold: geography, what people paid, who was there for the first time, what happened next. Almost all of it exists.
• Split your capital requirement by what the money is doing, rather than by what round you think you're raising.

The same questions play out differently in other sectors: see the pieces on climate, financial inclusion and food and agriculture.

Healthcare is the warmest sector in this lane. It's also the one where the wrong instrument costs the most, because the assets are heavy and the payback is slow.

If you want to know whether your healthcare business clears the four gates, and which instruments fit the assets you're funding, start with the Capital Roadmap Diagnostic.